Arab News, Sunday, Jan 29, 2023 | Rajab 7, 1444
11 agreements signed during global medical biotechnology summit in Saudi Arabia
Saudi Arabia: Eleven agreements were
signed during the Riyadh Global Medical Biotechnology Summit 2023, which
concluded in the Saudi capital on Thursday.
Delegates discussed a number of topics, ideas and
ambitions related to the biotech sector during the two-day event, with the aim
of helping to develop the field and enhance industrial and investment trends to
build a modern and innovative healthy industry, organizers said.
The speakers included local and international
experts and specialist researchers who explored topics that highlighted the
importance of international collaboration and global industrial-academic
cooperation to overcome unprecedented challenges in the health sector.
They stressed that investment in biotechnology
will help to develop new products and achieve economic growth through global
health solutions that advance scientific progress and innovation in industrial
technology.
Eleven memorandums of understanding and
cooperation agreements were signed during the summit between leading figures in
the medical biotech sector, government agencies, and international and national
companies.
An exhibition took place on the sidelines of the
event, featuring local and international drug and vaccine manufacturers, along
with research agencies and universities in the Kingdom. The participants
showcased their latest research and innovations relating to drugs and vaccines,
and their goals for enhancing drug security.
The summit was organized by the Ministry of
National Guard Health Affairs, King Abdullah International Medical Research
Center, and King Saud bin Abdulaziz University for Health Sciences, in
cooperation with the Ministry of Investment. It took place under the auspices of
Crown Prince Mohammed bin Salman and was inaugurated on his behalf by Minister
of the National Guard Prince Abdullah bin Bandar.
Organizers said the aim of the two-day event was
to highlight the importance of integration between ministries and other
government organizations to improve quality in fields related to medical
biotechnology.